{"entity":{"type":"insider","cik":"0001413616","url":"/insider/0001413616","json_url":"/insider/0001413616.json","name":"Pearce Michael Cooper","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":14,"first":"2011-08-31","last":"2020-08-26","span_basis":"filed_date"},"name_variants":[{"name":"Pearce Michael Cooper","source":"filing","n_filings":14,"first_seen":"2011-08-31","last_seen":"2020-08-26"}],"transactions":[{"id":2386303,"accession":"0000921895-20-002331","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000921895-20-002331","line_url":"/filing/0000921895-20-002331#line-2","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"HARPER ASSET MANAGEMENT LLC; Myrexis, Inc.; Couchman Family Fund; Xstelos Corp.; Pearce Michael Cooper; Harper Brian James; COUCHMAN JONATHAN","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":0.1913,"price_display":"0.19","price_state":"stated","total_value":4782.5,"total_display":"4,782.50","shares_owned_after":1590194.0,"shares_owned_after_display":"1,590,194","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-25","filed_date":"2020-08-26","scope":"insider"},{"id":2386298,"accession":"0000921895-20-002331","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000921895-20-002331","line_url":"/filing/0000921895-20-002331#line-1","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"HARPER ASSET MANAGEMENT LLC; Myrexis, Inc.; Couchman Family Fund; Xstelos Corp.; Pearce Michael Cooper; Harper Brian James; COUCHMAN JONATHAN","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52100.0,"shares_display":"52,100","price_per_share":0.1834,"price_display":"0.18","price_state":"stated","total_value":9555.14,"total_display":"9,555.14","shares_owned_after":1615194.0,"shares_owned_after_display":"1,615,194","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-24","filed_date":"2020-08-26","scope":"insider"},{"id":2134898,"accession":"0000921895-20-002115","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000921895-20-002115","line_url":"/filing/0000921895-20-002115#line-1","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"HARPER ASSET MANAGEMENT LLC; Myrexis, Inc.; Couchman Family Fund; Xstelos Corp.; Pearce Michael Cooper; Harper Brian James; COUCHMAN JONATHAN","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":506292.0,"shares_display":"506,292","price_per_share":0.2,"price_display":"0.20","price_state":"stated","total_value":101258.4,"total_display":"101,258.40","shares_owned_after":2100524.0,"shares_owned_after_display":"2,100,524","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-05","filed_date":"2020-08-06","scope":"insider"},{"id":2694779,"accession":"0001354488-12-006242","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001354488-12-006242","line_url":"/filing/0001354488-12-006242#line-4","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001413616","owner_name":"Pearce Michael Cooper","owner_url":"/insider/0001413616","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8843.0,"shares_display":"8,843","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":61901.0,"total_display":"61,901.00","shares_owned_after":36667.0,"shares_owned_after_display":"36,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-28","filed_date":"2012-11-29","scope":"insider"},{"id":2694769,"accession":"0001354488-12-006242","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001354488-12-006242","line_url":"/filing/0001354488-12-006242#line-2","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001413616","owner_name":"Pearce Michael Cooper","owner_url":"/insider/0001413616","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":7700.0,"total_display":"7,700.00","shares_owned_after":36667.0,"shares_owned_after_display":"36,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-27","filed_date":"2012-11-29","scope":"insider"},{"id":2431846,"accession":"0001354488-12-006210","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001354488-12-006210","line_url":"/filing/0001354488-12-006210#line-4","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001413616","owner_name":"Pearce Michael Cooper","owner_url":"/insider/0001413616","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25917.0,"shares_display":"25,917","price_per_share":7.1819,"price_display":"7.18","price_state":"stated","total_value":186133.3023,"total_display":"186,133.30","shares_owned_after":36667.0,"shares_owned_after_display":"36,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-26","filed_date":"2012-11-26","scope":"insider"},{"id":2431836,"accession":"0001354488-12-006210","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001354488-12-006210","line_url":"/filing/0001354488-12-006210#line-2","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001413616","owner_name":"Pearce Michael Cooper","owner_url":"/insider/0001413616","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8800.0,"shares_display":"8,800","price_per_share":7.413,"price_display":"7.41","price_state":"stated","total_value":65234.4,"total_display":"65,234.40","shares_owned_after":36667.0,"shares_owned_after_display":"36,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-23","filed_date":"2012-11-26","scope":"insider"},{"id":2930814,"accession":"0001354488-12-006165","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001354488-12-006165","line_url":"/filing/0001354488-12-006165#line-4","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001413616","owner_name":"Pearce Michael Cooper","owner_url":"/insider/0001413616","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3440.0,"shares_display":"3,440","price_per_share":7.3708,"price_display":"7.37","price_state":"stated","total_value":25355.552,"total_display":"25,355.55","shares_owned_after":36667.0,"shares_owned_after_display":"36,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-21","filed_date":"2012-11-23","scope":"insider"},{"id":2930801,"accession":"0001354488-12-006165","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001354488-12-006165","line_url":"/filing/0001354488-12-006165#line-2","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001413616","owner_name":"Pearce Michael Cooper","owner_url":"/insider/0001413616","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17242.0,"shares_display":"17,242","price_per_share":7.2341,"price_display":"7.23","price_state":"stated","total_value":124730.3522,"total_display":"124,730.35","shares_owned_after":36667.0,"shares_owned_after_display":"36,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-20","filed_date":"2012-11-23","scope":"insider"},{"id":3402593,"accession":"0001354488-12-006063","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001354488-12-006063","line_url":"/filing/0001354488-12-006063#line-4","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001413616","owner_name":"Pearce Michael Cooper","owner_url":"/insider/0001413616","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23208.0,"shares_display":"23,208","price_per_share":7.2706,"price_display":"7.27","price_state":"stated","total_value":168736.0848,"total_display":"168,736.08","shares_owned_after":36667.0,"shares_owned_after_display":"36,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-19","filed_date":"2012-11-19","scope":"insider"},{"id":3402589,"accession":"0001354488-12-006063","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001354488-12-006063","line_url":"/filing/0001354488-12-006063#line-2","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001413616","owner_name":"Pearce Michael Cooper","owner_url":"/insider/0001413616","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21634.0,"shares_display":"21,634","price_per_share":7.3,"price_display":"7.30","price_state":"stated","total_value":157928.2,"total_display":"157,928.20","shares_owned_after":36667.0,"shares_owned_after_display":"36,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-16","filed_date":"2012-11-19","scope":"insider"},{"id":3347758,"accession":"0001354488-12-005220","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001354488-12-005220","line_url":"/filing/0001354488-12-005220#line-4","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001413616","owner_name":"Pearce Michael Cooper","owner_url":"/insider/0001413616","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":800.0,"total_display":"800.00","shares_owned_after":36667.0,"shares_owned_after_display":"36,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-10-09","filed_date":"2012-10-09","scope":"insider"},{"id":3347752,"accession":"0001354488-12-005220","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001354488-12-005220","line_url":"/filing/0001354488-12-005220#line-2","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001413616","owner_name":"Pearce Michael Cooper","owner_url":"/insider/0001413616","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1188.0,"shares_display":"1,188","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":9504.0,"total_display":"9,504.00","shares_owned_after":36667.0,"shares_owned_after_display":"36,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-10-05","filed_date":"2012-10-09","scope":"insider"},{"id":2804204,"accession":"0001354488-12-005172","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001354488-12-005172","line_url":"/filing/0001354488-12-005172#line-5","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001413616","owner_name":"Pearce Michael Cooper","owner_url":"/insider/0001413616","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16472.0,"shares_display":"16,472","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":131776.0,"total_display":"131,776.00","shares_owned_after":36667.0,"shares_owned_after_display":"36,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-10-04","filed_date":"2012-10-04","scope":"insider"},{"id":2804197,"accession":"0001354488-12-005172","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001354488-12-005172","line_url":"/filing/0001354488-12-005172#line-3","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001413616","owner_name":"Pearce Michael Cooper","owner_url":"/insider/0001413616","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10749.0,"shares_display":"10,749","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":85992.0,"total_display":"85,992.00","shares_owned_after":36667.0,"shares_owned_after_display":"36,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-10-03","filed_date":"2012-10-04","scope":"insider"},{"id":2694686,"accession":"0001354488-12-000274","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001354488-12-000274","line_url":"/filing/0001354488-12-000274#line-2","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001413616","owner_name":"Pearce Michael Cooper","owner_url":"/insider/0001413616","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":10.0939,"price_display":"10.09","price_state":"stated","total_value":252347.5,"total_display":"252,347.50","shares_owned_after":26667.0,"shares_owned_after_display":"26,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-01-24","filed_date":"2012-01-25","scope":"insider"},{"id":8950827,"accession":"0001354488-11-003391","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001354488-11-003391","line_url":"/filing/0001354488-11-003391#line-4","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001413616","owner_name":"Pearce Michael Cooper","owner_url":"/insider/0001413616","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12600.0,"shares_display":"12,600","price_per_share":8.45,"price_display":"8.45","price_state":"stated","total_value":106470.0,"total_display":"106,470.00","shares_owned_after":26667.0,"shares_owned_after_display":"26,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-12","filed_date":"2011-09-13","scope":"insider"},{"id":8950825,"accession":"0001354488-11-003391","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001354488-11-003391","line_url":"/filing/0001354488-11-003391#line-2","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001413616","owner_name":"Pearce Michael Cooper","owner_url":"/insider/0001413616","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2100.0,"shares_display":"2,100","price_per_share":8.32,"price_display":"8.32","price_state":"stated","total_value":17472.0,"total_display":"17,472.00","shares_owned_after":26667.0,"shares_owned_after_display":"26,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-09","filed_date":"2011-09-13","scope":"insider"},{"id":8932708,"accession":"0001354488-11-003305","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001354488-11-003305","line_url":"/filing/0001354488-11-003305#line-4","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001413616","owner_name":"Pearce Michael Cooper","owner_url":"/insider/0001413616","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":8.36,"price_display":"8.36","price_state":"stated","total_value":12540.0,"total_display":"12,540.00","shares_owned_after":26667.0,"shares_owned_after_display":"26,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-08","filed_date":"2011-09-09","scope":"insider"},{"id":8932701,"accession":"0001354488-11-003305","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001354488-11-003305","line_url":"/filing/0001354488-11-003305#line-2","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001413616","owner_name":"Pearce Michael Cooper","owner_url":"/insider/0001413616","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":8.22,"price_display":"8.22","price_state":"stated","total_value":11508.0,"total_display":"11,508.00","shares_owned_after":26667.0,"shares_owned_after_display":"26,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-07","filed_date":"2011-09-09","scope":"insider"},{"id":8892098,"accession":"0001354488-11-003257","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001354488-11-003257","line_url":"/filing/0001354488-11-003257#line-2","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001413616","owner_name":"Pearce Michael Cooper","owner_url":"/insider/0001413616","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3468.0,"shares_display":"3,468","price_per_share":7.72,"price_display":"7.72","price_state":"stated","total_value":26772.96,"total_display":"26,772.96","shares_owned_after":27600.0,"shares_owned_after_display":"27,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-06","filed_date":"2011-09-07","scope":"insider"},{"id":8892095,"accession":"0001354488-11-003257","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001354488-11-003257","line_url":"/filing/0001354488-11-003257#line-1","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001413616","owner_name":"Pearce Michael Cooper","owner_url":"/insider/0001413616","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1132.0,"shares_display":"1,132","price_per_share":8.36,"price_display":"8.36","price_state":"stated","total_value":9463.52,"total_display":"9,463.52","shares_owned_after":31068.0,"shares_owned_after_display":"31,068","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-02","filed_date":"2011-09-07","scope":"insider"},{"id":9115899,"accession":"0001354488-11-003219","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001354488-11-003219","line_url":"/filing/0001354488-11-003219#line-2","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001413616","owner_name":"Pearce Michael Cooper","owner_url":"/insider/0001413616","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":8.76,"price_display":"8.76","price_state":"stated","total_value":4380.0,"total_display":"4,380.00","shares_owned_after":32200.0,"shares_owned_after_display":"32,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-01","filed_date":"2011-09-02","scope":"insider"},{"id":9115898,"accession":"0001354488-11-003219","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001354488-11-003219","line_url":"/filing/0001354488-11-003219#line-1","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001413616","owner_name":"Pearce Michael Cooper","owner_url":"/insider/0001413616","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":8.6,"price_display":"8.60","price_state":"stated","total_value":4300.0,"total_display":"4,300.00","shares_owned_after":32700.0,"shares_owned_after_display":"32,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-31","filed_date":"2011-09-02","scope":"insider"},{"id":9017809,"accession":"0001354488-11-003176","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001354488-11-003176","line_url":"/filing/0001354488-11-003176#line-2","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001413616","owner_name":"Pearce Michael Cooper","owner_url":"/insider/0001413616","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":8.63,"price_display":"8.63","price_state":"stated","total_value":3452.0,"total_display":"3,452.00","shares_owned_after":33200.0,"shares_owned_after_display":"33,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-30","filed_date":"2011-08-31","scope":"insider"},{"id":9017808,"accession":"0001354488-11-003176","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001354488-11-003176","line_url":"/filing/0001354488-11-003176#line-1","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001413616","owner_name":"Pearce Michael Cooper","owner_url":"/insider/0001413616","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":8.62,"price_display":"8.62","price_state":"stated","total_value":12068.0,"total_display":"12,068.00","shares_owned_after":33600.0,"shares_owned_after_display":"33,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-29","filed_date":"2011-08-31","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":23,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":23,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":23},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000727510","name":"ENZON PHARMACEUTICALS, INC.","url":"/issuer/0000727510","role":"Other","n_filings":2,"first_seen":"2020-08-06","last_seen":"2020-08-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001024126","name":"PERNIX THERAPEUTICS HOLDINGS, INC.","url":"/issuer/0001024126","role":"Director","n_filings":12,"first_seen":"2011-08-31","last_seen":"2012-11-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001413616","retrieved_at":"2026-08-22T00:04:52+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}